
Tomáš Cihlář
Tomáš Cihlář is a Czech virologist and biochemist known for his leadership in the biology department at Gilead Sciences. He has been instrumental in the development of groundbreaking antiviral medications, including Lenacapavir, a newly approved injection for HIV prevention. His work has significantly advanced efforts to combat viral infections, including the development of remdesivir during the COVID-19 pandemic.
Global Media Ratings
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Slovakia:
Tomáš Cihlář is a Czech virologist and biochemist who leads the biology department at Gilead Sciences and contributed to the development of the drug remdesivir during the COVID-19 pandemic.
8